2003
DOI: 10.1038/sj.ijo.0802262
|View full text |Cite
|
Sign up to set email alerts
|

Chromium picolinate for reducing body weight: Meta-analysis of randomized trials

Abstract: The aim of this meta-analysis was to assess the evidence of chromium picolinate for reducing body weight. Literature searches were conducted on Medline, Embase, The Cochrane Library, Amed and Ciscom. Nine experts and four manufacturers of commercial preparations containing chromium picolinate were asked to contribute published and unpublished studies. There were no restrictions regarding the language of publication. The screening of studies, selection, data extraction, validation and the assessment of methodol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
54
1
2

Year Published

2005
2005
2014
2014

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 116 publications
(60 citation statements)
references
References 57 publications
3
54
1
2
Order By: Relevance
“…Extensively studied with 2 metaanalyses (Pittler & Ernst, 2004;Pittler et al, 2003) and 1 review (Vincent, 2003). Supportive evidence is minimal.…”
Section: Calciummentioning
confidence: 99%
“…Extensively studied with 2 metaanalyses (Pittler & Ernst, 2004;Pittler et al, 2003) and 1 review (Vincent, 2003). Supportive evidence is minimal.…”
Section: Calciummentioning
confidence: 99%
“…26 A meta-analysis of 10 double-blind, placebo-controlled trials provides evidence of a relatively small reduction in body weight (1.1-1.2 kg over 10-13 weeks) in overweight and obese individuals receiving chromium picolinate. 27 This trial was designed to assess the effects of chromium picolinate supplementation alone and combined with a nutrition education intervention on weight loss in both men and women, and to assess any effects attributable to anthropometry (body fat distribution).…”
Section: Introductionmentioning
confidence: 99%
“…A meta-analysis included 10 double-blind RCTs (Table 1). 33 The results suggest a reduction of 1. . It was concluded that the data suggest a small 34 effect compared with placebo, which has to be interpreted with caution due to the lack of robustness of the effect, which is largely dependent on a single trial.…”
Section: Mh Pittler and E Ernstmentioning
confidence: 87%